Microbiological diagnostic procedures in respiratory infections: suppurative lung disease

Paediatric Respiratory Reviews

Volumn 8, Issue 3, 2007, Pages 185-194

  May, M L ^a   Robson, J ^a  

^a Sullivan Nicolaides Pathology ^*  (Australia)

Author keywords

Antibiotic; Bronchiectasis; Bronchoalveolar lavage; Child; Culture; Cystic fibrosis; Lung abscess; Microbiology; Pneumonia

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM DERIVATIVE; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COLISTIN; COTRIMOXAZOLE; MACROLIDE; PENICILLIN G; TIMENTIN; TOBRAMYCIN;

ACUTE DISEASE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM CULTURE; BLOOD CULTURE; BRONCHIECTASIS; CHROMOBACTERIUM VIOLACEUM; CHRONIC DISEASE; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; HUMAN; INFECTION CONTROL; LEMIERRE SYNDROME; LUNG ABSCESS; LUNG DISEASE; LUNG LAVAGE; MELIOIDOSIS; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; PLEURA EMPYEMA; PNEUMONIA; PRIORITY JOURNAL; QUALITY CONTROL; RESPIRATORY TRACT INFECTION; REVIEW; SEROLOGY; SPUTUM;

CHILD; HUMANS; LUNG ABSCESS; MICROBIOLOGICAL TECHNIQUES; REPRODUCIBILITY OF RESULTS;

EID: 34548823780     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2007.08.009     Document Type: Review

References (67)

1. Valery P.C., Torzillo P.J., and Mulholland K. Hospital-based case-control study of bronchiectasis in indigenous children in Central Australia. Pediatr Infect Dis J 23 (2004) 902-908
2. Chang A.B., Grimwood K., Mulholland E.K., et al. Bronchiectasis in indigenous children in remote Australian communities. Med J Aust 177 (2002) 200-204
3. Garau J. Why do we need to eradicate pathogens in respiratory tract infections?. Int J Infect Dis 7 Suppl 1 (2003) S5-S12
4. Sharp S.E., Robinson A., Saubolle M., et al. Lower Respiratory Tract Infections (2004), ASM Press, Washington DC pp. 3-12
5. Rozon B., Carratala J., Verdaguer R., Dorca J., Manresa F., and Guidiol F. Prospective study of the usefulness of sputum Gram stain in the initial approach to community acquired pneumonia requiring hospitalization. Clin Infect Dis 31 (2000) 869-874
6. Medline Plus [Internet] Bethesda (MD). National Library of Medline (US);[updated 2005 August 12]. Gastric culture [updated 16/6/05; reviewed 6/3/07; cited 2007 March 26] Available from: www.nlm.nih.gov/medlineplus.
7. Smyth A. Update on treatment of pulmonary exacerbations in cystic fibrosis. Curr Opin Pulm Med 12 (2006) 440-444
8. Miller M.B., and Gilligan P.H. Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis. J Clin Microbiol 41 (2003) 4009-4015
9. De Boeck K., Alifier M., and Vandeputte S. Sputum induction in young cystic fibrosis patients. Eur Respir J 16 (2000) 91-94
10. Fishman J.A., Roth R.S., Zanzot E., Enos E.J., and Ferraro M.J. Use of induced sputum specimens for microbiologic diagnosis of infections due to organisms other than Pneumocystis carinii. J Clin Microbiol 32 (1994) 131-134
11. Ho S.A., Ball R., Morrison L.J., Brownlee K.G., and Conway S.P. Clinical value of obtaining sputum and cough swab samples following inhaled hypertonic saline in children with cystic fibrosis. Pediatr Pulmonol 38 (2004) 82-87
12. Armstrong D.S., Grimwood K., Carlin J.B., Carzino R., Olinsky A., and Phelan P.D. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr Pulmonol 21 (1996) 267-275
13. Rosenfeld M., Emerson J., Accurso F., et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol 28 (1999) 321-328
14. Taylor L., Corey M., Matlow A., Sweezey N.B., and Ratjen F. Comparison of throat swabs and nasopharyngeal suction specimens in non-sputum-producing patients with cystic fibrosis. Pediatr Pulmonol 41 (2006) 839-843
15. Wood R.E. The diagnostic effectiveness of the flexible bronchoscope in children. Pediatr Pulmonol 1 (1985) 188-192
16. Balfour-Lynn I.M., Abrahamson E., Cohen G., et al. BTS guidelines for the management of pleural infection in children. Thorax 60 Suppl 1 (2005) 1-21
17. Gutierrez J.P., Grimwood K., Armstrong D.S., et al. Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis. Eur Respir J 17 (2001) 281-286
18. Labenne M., Poyart C., Rambaud C., et al. Blind protected specimen brush and bronchoalveolar lavage in ventilated children. Crit Care Med 27 (1999) 2537-2543
19. Thorpe J., Baugham R., Frame P.T., Wesseler T.A., and Staneck J.L. Bronchoalveolar lavage for diagnosing acute bacterial pneumonia. J Infect Dis 155 (1987) 855-861
20. Marchant J.M., Masters I.B., Taylor S.M., Cox N.C., Seymour G.J., and Chang A.B. Evaluation and outcome of young children with chronic cough. Chest 129 (2006) 1132-1141
21. Riedler J., Grigg J., and Robertson C.F. Role of bronchoalveolar lavage in children with lung disease. Eur Respir J 8 (1995) 1725-1730
22. Chan C.C., Abi-Saleh W.J., Arroliga A.C., et al. Diagnostic yield and therapeutic impact of flexible bronchoscopy in lung transplant recipients. J Heart Lung Transplant 15 (1996) 196-205
23. Kahn F.W., and Jones J.M. Diagnosing bacterial respiratory infection by bronchoalveolar lavage. J Infect Dis 155 (1987) 862-869
24. Le Monnier A., Carbonnelle E., Zahar J.R., et al. Microbiological diagnosis of empyema in children: comparative evaluations by culture, polymerase chain reaction, and pneumococcal antigen detection in pleural fluids. Clin infect Dis 42 (2006) 1135-1140
25. Byington C.L., Spencer L.Y., Johnson T.A., et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis 34 (2002) 434-440
26. Tseng Y., Wu M.H., Lin M.Y., Lai W.W., and Liu C.C. Surgery for lung abscess in immunocompetent and immunocompromised children. J Pediatr Surg 36 (2001) 470-473
27. Chirinos J.A., Lichtstein D.M., Garcia J., and Tamariz L.J. The evolution of Lemierre syndrome: report of 2 cases and review of the literature. Medicine (Baltimore) 81 (2002) 458-465
28. Currie B.J., Fisher D.A., Howard D.M., et al. Endemic melioidosis in Tropical Northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis 31 (2000) 981-986
29. Suputtamongkol Y., Hall A.J., Dance D.A.B., et al. Epidemiology of melioidosis in Uban Ratchatani, northeast Thailand. Int J Epidemiol 23 (1994) 1082-1090
30. How H.S., Ng K.H., Yeo H.B., et al. Pediatric melioidosis in Paheng, Malaysia. J Microbiol Immunol Infect 38 (2005) 314-319
31. Lumbiganon P., and Viengnondha S. Clinical manifestations of melioidosis in children. Pediatr Infect Dis J 14 (1995) 136-140
32. Gilligan P., Lum G., Vandamme P., and Whittier S. Burkholderia, Stenotrophomonas, Ralstonia, Brevunidmonas, Comamonas, Delftia, Pandoraea, and Acidovorax. In: Murray P.R., Baron E.J., Jorgensen J.H., Pfaller M., and Yolken R.H. (Eds). Manual of Clinical Microbiology. 8th Edition (2003), ASM Press, Washington DC 729-738
33. von Graevenitz A., Zbinden R., and Mutters R. Actinobacillus, Capnocytophaga, Eikenella, Kingella, Pasturella, and other fastidious or rarely encountered Gram-negative rods. In: Murray P.R., Baron E.J., Jorgensen J.H., Pfaller M., and Yolken R.H. (Eds). Manual of Clinical Microbiology. 8th Edition (2003), ASM Press, Washington DC 616-619
34. Sirinavin S., Techasaensiri C., and Benjaponpitak S. Invasive Chromobacterium violaceum infection in children: Case report and review. Pediatr Infect Dis J 24 (2005) 559-561
35. Levison J., Van Asperen P., Wong C., et al. The value of a CT-guided fine needle aspirate in infants with lung abscess. J Paediatr Child Health 40 (2004) 474-476
36. Lee S.K., Morris R.F., and Cramer B. Percutaneous needle aspiration of neonatal lung abscesses. Pediatr Radiol 21 (1991) 254-257
37. Hoffer F.A., Bloom D.A., Colin A.A., and Fishman S.J. Lung abscess versus necrotising pneumonia: implications for interventional therapy. Pediatr Radiol 29 (1999) 87-91
38. Wali S.O., Shugaeri A., Samman Y.S., and Abdelaziz M. Percutaneous drainage of pyogenic lung abscess. Scand J Infect Dis 34 (2002) 673-679
39. Brook I., and Finegold S.M. The bacteriology and therapy of lung abscess in children. J Pediatr 94 (1979) 10-14
40. Yagupsky P., Dagan R., Howard C.W., Einhom M., Kassis I., and Simu A. High prevalence of Kingella kingae in joint fluid from children with septic arthritis revealed by the BACTEC blood culture system. J Clin Microbiol 30 (1992) 1278-1281
41. Vuori-Holopainen E., and Peltola H. Reappraisal of lung tap: Review of an old method for better etiologic diagnosis of childhood pneumonia. Clin Infect Dis 32 (2001) 715-726
42. Ploton C., Freydiere A.M., Benito Y., et al. Streptococcus pneumoniae thoracic empyema in children: rapid diagnosis by using the Binax NOW immunochromatographic membrane test in pleural fluids. Pathol Biol (Paris) 54 (2006) 498-501
43. Light R.W. Pleural diseases. Dis Mon 38 (1992) 261-331
44. Utine G.E., Ozcelik U., Yalcin E., et al. Childhood parapneumonic effusions: biochemical and inflammatory markers. Chest 128 (2005) 1436-1441
45. Gilligan P.H., Kiska D.L., and Appleman M.D. Cumitech 43, Cystic Fibrosis Microbiology (2006), ASM Press, Washington DC p. 22
46. Roche P., Krause V., Cook H., et al. Invasive Pneumococcal Disease in Australia 31 1 (2005) 86-100 CDI 2007
47. Moskowitz S.M., Foster J.M., Emerson J., and Bums J.L. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol 42 (2004) 1915-1922
48. Morosini M., Garcia-Castillo M., Loza E., Perez-Vazquez M., Baquero F., and Canton R. Breakpoints for predicting Pseudomonas aeruginosa susceptibility to inhaled tobramycin in cystic fibrosis patients: Use of high-range E test strips. J Clin Microbiol 43 (2005) 4480-4485
49. Aaron S.D., Ferris W., Ramotar K., Vandemheen K., Chan F., and Saginur R. Single and combination antibiotic susceptibilities of planktonic adherent and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis. J Clin Microbiol 40 (2002) 4172-4179
50. White R.L., Burgess D.S., Manduru M., and Bosso J.A. Comparison of three different in vitro methods of detecting synergy: Time kill, checkerboard and E test. Antimicrob Agents Chemother 40 (1996) 1914-1918
51. Aaron S.D., Vandemheen K.L., Ferris W., et al. Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomized, double-blind, controlled clinical trial. Lancet 366 (2005) 463-471
52. Sader H.S., and Jones R.N. Antimicrobial susceptibility of uncommonly isolated non-enteric Gram negative bacilli. Int J Antimicrob Agents 25 (2005) 95-109
53. Tristram S. Haemophilus influenzae and Antimicrobial Suceptibility. In: Merlino J. (Ed). Antimicrobial Susceptibility Testing: Methods and Practices with an Australian Perspective (2004), The antimicrobial Special interest Group of the Australian Society for Microbiology, Sydney 169-170 Chapter 7
54. Syrmis M.W., O'Carroll M.R., Sloots T.P., et al. Rapid genotyping of Pseudomonas aeruginosa isolates harboured by adult and paediatric patients with cystic fibrosis using repetitive-element-based PCR assays. J Medical Microbiol 53 (2004) 1089-1096
55. Isles A., Maclusky I., Corey M., et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 104 (1984) 206-210
56. Whiteford M.L., Wilkinson J.D., McColl J.H., et al. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak. Thorax l50 (1995) 194-198
57. Mahenthiralingam E., Van Damme P., Campbell M.E., et al. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Clin Infect Dis 33 (2001) 1469-1475
58. Guide S.V., Stock F., Gill V.J., et al. Reinfection rather than persistent infection in patients with chronic granulomatous disease. J Infect Dis 187 (2003) 845-853
59. Ledson M.J., Gallagher M.J., and Walshaw M.J. Chronic Burkholderia cepacia bronchiectasis in a non-cystic fibrosis individual. Thorax 53 (1998) 430-432
60. Ishizuka T., Oyama T., Sato M., et al. Fatal pneumonia caused by Burkholderia cepacia nine months after resection of aspergilloma. Respirology 8 (2003) 401-403
61. De Soyza A., McDowell A., Archer L., et al. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 358 (2001) 1780-1781
62. Saiman L., and Siegel J. Cystic fibrosis foundation consensus conference on infection control participants. Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemol 24 Suppl 5 (2003) S1-S52
63. Labarca J.A., Trick W.E., Peterson C.L., et al. A multistate nosocomial outbreak of Ralstonia pickettii colonization associated with an intrinsically contaminated respiratory care solution. Clin Infect Dis 29 (1999) 1281-1286
64. Goussard P., Gie R.P., Steyn F., et al. Pasturella multocida lung and liver abscess in an immune-competent child. Pediatr Pulmonol 41 (2006) 275-278
65. Adhisivam B., Mahadevan S., and Udaykumar C. Lung abscess caused by salmonella. Indian J Pediatr 73 (2006) 450-451
66. Chan P.C., Huang L.M., Wu P.S., et al. Clinical management and outcome of childhood lung abscess: a 16 year experience. J Microbiol Immunol Infect 38 (2005) 183-188
67. Dagli E. Non cystic fibrosis bronchiectasis. Paediatr Resp Rev 1 (2000) 64-70